ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

3 links0 made here, not in the record4 judgments2 judges (the rules as one: Rule based)1 record change seen
GPT-6.1 Sol (High)Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT02635035Shire SCT: LisdexamfetamineTreatment for ADHD and SCTNYU Langone HealthPhase 2 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSAttention Deficit Disorder …The registry's MeSH filing›As of now · Rule based · Main conditionMain conditionHyperkinesisNo longer in the registry's filing›Oct 20 · GPT-6.1 Sol (High) · Finer: Attention Deficit Disorder with HyperactivityNov 19 · Rule based · The filing now says what the reading saidThe filing now says what the read…DRUGSLisdexamfetamineIntervention entry›Nov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Hyperkinesis

From the registry record2 judgments on this link
Fit of the first condition term, from the registry to what was judged
RegistryHyperkinesis, once filedthe registry files the study under it
→judged
Since that reading
→
On the pageNo longer linkedthe registry no longer files it here

All judgments on this study

WhenLinkJudgeDecisionState
Oct 20HyperkinesisGPT-6.1 Sol (High)Finer: Attention Deficit Disorder with HyperactivityCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 18LisdexamfetamineRule based · role ruleTestedCurrent
Nov 19HyperkinesisRule based · nightly checkThe filing now says what the reading saidCurrent
As of nowAttention Deficit Disorder with HyperactivityRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

When a study changes after it was read

Every night, studies whose record changed are compared with the last reading. A change to sites or dates leaves the reading as it is; a reworded entry keeps it; a change to the treatments or conditions marks it to be read again.

Until it is read again, the page shows the last reading and says so.